Injection, perflutren lipid microspheres, mil (1 mil dosage). N/A. N/A. $30.77. Q9957 - Definity. (price per mL). Injection, perflutren lipid microspheres, mil
The perflutren lipid microspheres exhibit lower acoustic impedance than blood and enhance the intrinsic backscatter of blood. Mechanism of action. Perflutren is
FDA approves Perflutren Lipid Microsphere for pediatric patients with suboptimal echocardiograms The federal agency approved Perflutren Lipid
Vial for (Perflutren Lipid Microsphere) Injectable Suspension For Intravenous Use DESCRIPTION The DEFINITY vial contains components that upon activation yield perflutren lipid microspheres, a diagnostic drug that is intended to be used for contrast enhancement during the indicated echocardiographic procedures.
The perflutren lipid microspheres are composed of octafluoropropane encapsulated in an outer lipid shell consisting of (R) – hexadecanoic acid, 1
perflutren lipid microspheres and perflutren protein type A microspheres. It contains microspheres of heat-treated human albumin containing perflutren
Last October it requested Lantheus Medical Imaging's Definity (perflutren lipid microspheres) and GE Healthcare's Optison (perflutren protein-type A
The perflutren lipid microspheres exhibit lower acoustic impedance than blood and enhance the intrinsic backscatter of blood. Mechanism of action: Perflutren
(perflutren with a lipid shell; Definity/Luminity), and The contrast agent Lumason (sulfur hexafluoride lipid microspheres)
Comments